European Patent Office

8th May 2018

According to Life Sciences IP Review, the European Patent Office (EPO) has revoked a patent covering Mylan’s EpiPen (epinephrine) injector.

OPUS IP on X (formerly Twitter)…

Twitter feed is not available at the moment.

RECENT PATENT NEWS…

Corteva’s Field Trials Didn’t Undermine Its Seed-Patent Rights - Bloomberg Law News
FTC: Amgen patent arguments a “mockery of Section 2” - Global Competition Review
Wasif Qureshi Discusses the Rise of Patent and Trade Secret Disputes in the Data Center Industry - Jackson Walker LLP
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says - Reuters

UK BUSINESS NEWS…

Canada 'should fight' as US trade deadline looms, Manitoba premier says
Watch: How does the US national debt affect consumers around the world?
US borrowing costs rise as attempts to ease rates prove short-lived
Royal Mail misses delivery targets again but hails 'encouraging' signs

Designed by Industrial Action

Copyright © 2026 OPUS IP Limited. All Rights Reserved

OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION